Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients With Refractory Meningeal Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00005811
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:22.049412+00:00
Published At
2013-02-21T00:00:00+00:00
Record Updated At
2013-02-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["AIDS-related Diffuse Large Cell Lymphoma", "AIDS-related Diffuse Mixed Cell Lymphoma", "AIDS-related Diffuse Small Cleaved Cell Lymphoma", "AIDS-related Immunoblastic Large Cell Lymphoma", "AIDS-related Lymphoblastic Lymphoma", "AIDS-related Peripheral/Systemic Lymphoma", "AIDS-related Primary CNS Lymphoma", "AIDS-related Small Noncleaved Cell Lymphoma", "Childhood Diffuse Large Cell Lymphoma", "Childhood Immunoblastic Large Cell Lymphoma", "HIV-associated Hodgkin Lymphoma", "Leptomeningeal Metastases", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Medulloblastoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Unspecified Childhood Solid Tumor, Protocol Specific"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-02-21"
protocolSection.identificationModule.nctId
"NCT00005811"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients With Refractory Meningeal Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • AIDS-related Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Peripheral/Systemic Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Primary CNS Lymphoma (protocolSection.conditionsModule.conditions)
  • AIDS-related Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • HIV-associated Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Leptomeningeal Metastases (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent/Refractory Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Unspecified Childhood Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.